Dietary fiber gap and host gut microbiota

Protein and Peptide Letters

Volumn 24, Issue 5, 2017, Pages 388-396

  Han, Meng ^a   Wang, Congmin ^b   Liu, Ping ^a   Li, Defa ^c   Li, Yuan ^c   Ma, Xi ^a,d  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Fiber gap; Gut microbiota; Host health; Metabolic disease; Microbiota accessible carbohydrate; Protein turnover

Indexed keywords

COLORECTAL CANCER; DIETARY FIBER; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LIVER DISEASE; METABOLIC SYNDROME X; MICROBIAL DIVERSITY; NERVOUS SYSTEM; NONHUMAN; OBESITY; REVIEW; ANIMAL; COLORECTAL TUMOR; FEEDING BEHAVIOR; METABOLISM; MOUSE; PHYSIOLOGY;

G PROTEIN COUPLED RECEPTOR; VOLATILE FATTY ACID;

ANIMALS; COLORECTAL NEOPLASMS; DIETARY FIBER; FATTY ACIDS, VOLATILE; FEEDING BEHAVIOR; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; METABOLIC SYNDROME X; MICE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85020206091     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866524666170220113312     Document Type: Review

References (91)

1. Logan, A.C.; Jacka, F.N.; Prescott, S.L. Immune-microbiota interactions: Dysbiosis as a global health issue. Curr. Allergy Asthm. R., 2016, 16, 1-9.
2. Segata N. Gut microbiome: Westernization and the disappearance of intestinal diversity. Curr. Bio., 2015, 25, R611-R613.
3. Martínez, I.; Lattimer, J.M.; Hubach, K.L.; Case, J.A.; Yang, J.; Weber, C.G.; Haub, M.D. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J., 2013, 7, 269-280.
4. Martínez, I.; Stegen, J.C.; Maldonado-Gómez, M.X.; Eren, A.M.; Siba, P.M.; Greenhill, A.R.; Walter, J. The gut microbiota of rural papua new guineans: Composition, diversity patterns, and ecological processes. Cell Rep., 2015, 11, 527-538.
5. Jones, J.M. CODEX-aligned dietary fiber definitions help to bridge the 'fiber gap'. Nutr. J., 2014, 13, 1.
6. He, L.; Eslamfam, S.; Ma X.; Li D. Autophagy and the nutritional signaling pathway. Front. Agr. Sci. Eng., 2016, 3, 222-230.
7. Sonnenburg, E.D.; Smits, S.A.; Tikhonov, M.; Higginbottom, S.K.; Wingreen, N.S.; Sonnenburg, J.L. Diet-induced extinctions in the gut microbiota compound over generations. Nature, 2016, 529(7585), 212-215.
8. Deehan, E.C.; Walter, J. The fiber gap and the disappearing gut microbiome: Implications for human nutrition. Trends Endocrin. Met., 2016, 27, 239-242.
9. Storey, M.; Anderson, P. Income and race/ethnicity influence dietary fiber intake and vegetable consumption. Nutr. Res., 2014, 34, 844-850.
10. O'Keefe, S.J.; Li, J.V.; Lahti, L.; Ou, J.; Carbonero, F.; Mohammed, K.; Vipperla, K. Fat, fibre and cancer risk in African, Americans and rural Africans. Nat. Commun., 2015, 6.
11. Donaldson, G.P.; Lee, S.M.; Mazmanian, S.K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol., 2016, 14, 20-32.
12. Fernández, L.; Langa, S.; Martín, V.; Maldonado, A.; Jiménez, E.; Martín, R.; Rodríguez, J.M. The human milk microbiota: Origin and potential roles in health and disease. Pharmacol. Res., 2013, 69, 1-10.
13. Rogier, E.W.; Frantz, A.L.; Bruno, M.E.; Wedlund, L.; Cohen, D.A.; Stromberg, A.J.; Kaetzel, C.S. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc. Natl. Acad. Sci., 2014, 111, 3074-3079.
14. Wang, W.; Yang, Q.; Sun, Z.; Chen, X.; Yang, C.; Ma, X. Editorial: Advance of interactions between exogenous natural bioactive peptides and intestinal barrier and immune responses. Curr. Protein Pept. Sci., 2015, 16, 574-575.
15. Marcobal, A.; Barboza, M.; Sonnenburg, E.D.; Pudlo, N.; Martens, E.C.; Desai, P.; Sonnenburg, J.L. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe, 2011, 10(5), 507-514.
16. Lee, K.A.; Kim, S.H.; Kim, E.K.; Ha, E.M.; You, H.; Kim, B.; Lee, W.J. Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell, 2013, 153, 797-811.
17. Macfarlane, G.T.; Macfarlane, S. Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Intl., 2012, 95, 50-60.
18. Human microbiome project consortium. Structure, function and diversity of the healthy human microbiome. Nature, 2012, 486, 207-214.
19. Seedorf, H.; Griffin, N.W.; Ridaura, V.K.; Reyes, A.; Cheng, J.; Rey, F.E.; Spormann, A.M. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell, 2014, 159, 253-266.
20. Frost, G.; Sleeth, M.L.; Sahuri-Arisoylu, M.; Lizarbe, B.; Cerdan, S.; Brody, L.; Anastasovska, J.; Ghourab, S.; Hankir, M.; Zhang, S. The short chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun., 2014, 5, 3611.
21. Wang, J.; Han, M.; Zhang, G.; Qiao, S.; Li, D.; Ma, X. The signal pathway of antibiotic alternatives on intestinal microbiota and immune function. Curr. Protein Pept. Sci., 2016, 17, 785-796.
22. Yu, Z.T.; Chen, C.; Kling, D.E.; Liu, B.; McCoy, J.M.; Merighi, M.; Newburg, D.S. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology, 2013, 23, 169-177.
23. Ma, X.; Fan, P.; Li, L.; Qiao, S.; Zhang, G.; Li, D. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions. J. Anim. Sci., 2012, 90(4), 266-268.
24. Koh, A.; De Vadder, F.; Kovatcheva-Datchary, P.; Bäckhed, F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell, 2016, 165, 1332-1345.
25. Faith, J.J.; Guruge, J.L.; Charbonneau, M.; Subramanian, S.; Seedorf, H.; Goodman, A.L.; Rosenbaum, M. The long-term stability of the human gut microbiota. Science, 2013, 341, 1237439.
26. Koropatkin, N.M.; Cameron, E.A.; Martens, E.C. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol., 2012, 10, 323-335.
27. Chen, J.; Li, Y.; Tian, Y.; Huang, C.; Li, D.; Zhong, Q.; Ma, X. Interaction between microbes and host intestinal health: Modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr. Protein Pept. Sci., 2015, 16, 592-603.
28. Martens, E.C. Microbiome: Fibre for the future. Nature, 2016, 529, 158-159.
29. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Biddinger, S.B. Diet rapidly and reproducibly alters the human gut microbiome. Nature, 2014, 505, 559-563.
30. Sonnenburg, J.L.; Bäckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature, 2016, 535, 56-64.
31. Huang, C.; Song, P.X.; Fan, P.X.; Hou, C.L.; Thacker, P.A.; Ma, X. Dietary sodium butyrate decreased postweaning diarrhea by modulating intestinal permeability and changing the bacterial community in weaned piglets. J. Nutr., 2015, 145, 2774-80.
32. Kaoutari, A.E.; Armougom, F., Gordon, J.I.; Raoult, D.; Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol., 2013, 11, 497-504.
33. Goodrich, J.K.; Davenport, E.R.; Waters, J.L.; Clark, A.G.; Ley, R.E. Cross-species comparisons of host genetic associations with the microbiome. Science, 2016, 352, 532-535.
34. Martínez, I.; Muller, C.E.; Walter, J. Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species., PloS ONE, 2013, 8, e69621.
35. Yu, Z.T.; Chen, C.; Newburg, D.S. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology, 2013, cwt065.
36. Huang, C.; Zang, J.; Song, P.; Fan, P.; Chen, J.; Liu, D.; He, P.; Ma, X. Effects of particle size and drying methods of corn on growth performance, digestibility and haematological and immunological characteristics of weaned piglets. Arch. Anim. Nutr., 2015, 69, 30-45.
37. Sonnenburg, E.D.; Zheng, H.; Joglekar, P.; Higginbottom, S.K.; Firbank, S.J.; Bolam, D.N.; Sonnenburg, J.L. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell, 2010, 141, 1241-1252.
38. Fan, P.; Tan, Y.; Jin, K.; Lin, C.; Xia, S.; Han, B.; Zhang, F.; Wu, L.; Ma, X. Supplemental lipoic acid relieves post-weaning diarrhoea by decreasing intestinal permeability in rats. J. Anim. Physiol. Anim. Nutr. (Berl)., 2015 (In press).
39. Brüssow, H.; Parkinson, S.J. You are what you eat. Nat. Biotechnol., 2014, 32, 243-245.
40. Fan, P.; Li, L.; Rezaei, A.; Eslamfam, S.; Che. D.; Ma, X. Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr. Protein Pept. Sci. 2015, 16, 646-654.
41. Tremaroli, V.; Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature, 2012, 489, 242-249.
42. Knip, M.; Siljander, H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat. Rev. Endocrin., 2016.
43. Mazmanian, S.K.; Liu, C.H.; Tzianabos, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 2005, 122, 107-118.
44. Marchesi, J.R.; Adams, D.H.; Fava, F.; Hermes, G.D.; Hirschfield, G.M.; Hold, G.; Thomas, L.V. The gut microbiota and host health: A new clinical frontier. Gut, 2016, 65, 330-339.
45. Thaiss, C.A.; Zmora, N.; Levy, M.; Elinav, E. The microbiome and innate immunity. Nature, 2016, 535, 65-74.
46. Hold, G.L.; Smith, M.; Grange, C. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J. Gastroenterol, 2014, 20, 1192-210.
47. Swidsinski, A.; Weber, J.; Loening-Baucke, V. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol, 2005, 43, 3380-3389.
48. Mukhopadhya, I.; Thomson, J.M.; Hansen, R. Detection of campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE, 2011, 6, e21490.
49. Erickson, A.R.; Cantarel, B.L.; Lamendella, R. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE, 2012, 7, e49138.
50. Zang, J.; Chen, J.; Wang, A.; Liu, H.; Hu, S.; Che, X.; Ma, Y.; Wang, J.; Wang, C.; Du, G.; Ma, X. Effects of magnesium on the performance of sows and their piglets. J. Anim. Sci. Biotech., 2014, 5, 39.
51. Wynn, T.A.; Chawla, A.; Pollard, J.W. Macrophage biology in development, homeostasis and disease. Nature, 2013, 496, 445-455.
52. Cuskin, F.; Lowe, E.C.; Temple, M.J.; Zhu, Y.; Cameron, E.A.; Pudlo, N.A.; Rogowski, A. Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature, 2015, 517, 165-169.
53. Yan, A.W.; Fouts, D.E.; Brandl, J. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatol., 2011, 53, 96-105.
54. Lee, S.M.; Donaldson, G.P.; Mikulski, Z.; Boyajian, S.; Ley, K.; Mazmanian, S.K. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature, 2013, 501, 426-429.
55. Maltby, R.; Leatham-Jensen, M.P.; Gibson, T., Cohen, P.S.; Conway, T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157: H7 in the mouse intestine. PLoS ONE, 2013, 8, e53957.
56. Sonnenburg, J.L.; Xu, J.; Leip, D.D.; Chen, C.H.; Westover, B.P.; Weatherford, J.; Gordon, J.I. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science, 2005, 307, 1955-1959.
57. Liu, H.; Zhang, J.; Zhang, S.; Yang, F.; Thacker, P. A.; Zhang, G.; Qiao, S.; Ma, X. Oral administration of Lactobacillus fermentum I5007 favors intestinal development and alters the intestinal microbiota in formula-fed piglets. J. Agric. Food Chem., 2014, 62, 860-866.
58. Rooks, M.G.; Garrett, W.S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol., 2016, 16, 341-352.
59. De Souza, H.S.; Fiocchi, C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. Gastroenterol. Hepatol., 2015.
60. Honda, K.; Littman, D.R. The microbiota in adaptive immune homeostasis and disease. Nature, 2016, 535, 75-84.
61. Sansonetti, P.J.; Medzhitov, R. Learning tolerance while fighting ignorance. Cell, 2009, 138, 416-420.
62. Todd, J.A. D'oh! Genes and environment cause Crohn's disease. Cell, 2010, 141, 1114-1116.
63. Bäumler, A.J.; Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature, 2016, 535, 85-93.
64. Buffington, S.A.; Di Prisco, G.V.; Auchtung, T.A.; Ajami, N.J.; Petrosino, J.F.; Costa-Mattioli, M. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell, 2016, 165, 1762-1775.
65. Pamer, E.G. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science, 2016, 352, 535-538.
66. Garrett, W.S.; Lord, G.M.; Punit, S.; Lugo-Villarino, G.; Mazmanian, S.K.; Ito, S.; Glimcher, L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell, 2007, 131, 33-45.
67. Maslowski, K.M.; Vieira, A.T.; Ng, A.; Kranich, J.; Sierro, F.; Yu, D.; Xavier, R.J. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 2009, 461, 1282-1286.
68. Samuel, B.S.; Shaito, A.; Motoike, T.; Rey, F.E.; Backhed, F.; Manchester, J.K.; Gordon, J.I. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. P. Natl. Acad. Sci., 2008, 105, 16767-16772.
69. Jin, C.; Henao-Mejia, J.; Flavell, R.A. Innate immune receptors: Key regulators of metabolic disease progression. Cell Metab., 2013, 17, 873-882.
70. Sivan, A. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 2015, 350, 1084-1089.
71. Irrazábal, T.; Belcheva, A.; Girardin, S.E.; Martin, A.; Philpott, D.J. The multifaceted role of the intestinal microbiota in colon cancer. Mol. Cell, 2014, 54, 309-320.
72. Zmora, N., Zeevi, D., Korem, T., Segal, E.; Elinav, E. Taking it personally: Personalized utilization of the human microbiome in health and disease. Cell Host Microbe, 2016, 19, 12-20.
73. Sivan, A.; Corrales, L.; Hubert, N.; Williams, J. B.; Aquino-Michaels, K.; Earley, Z.M.; Chang, E.B. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 2015, 350, 1084-1089.
74. Murdoch, T.B. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease. Inflamm. Bowel Dis., 2012, 18, 1743-1748.
75. Hansen, R. Microbiota of de-novo pediatric IBD: Increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am. J. Gastroenterol., 2012, 107, 1913-1922.
76. Pirzer, U.; Schonhaar, A.; Fleischer, B.; Hermann, E. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet, 1991, 338, 1238-1239.
77. Mazmanian, S.K.; Round, J.L.; Kasper, D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 2008, 453, 620-625.
78. Sokol, H. Faecalibacterium prausnitzii is an anti inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA, 2008, 105, 16731-16736.
79. Gevers, D. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe, 2014, 15, 382-392.
80. Ma, X.; Zhang, S.; He, L.; Rong, Y.; Wilz, L.M.; Sun, Q.; Liu, R.; Fan, W.; Chen, S.; Yue, Z.; Kim, J.; Guan, K.L.; Li, D.; Zhong, Q. MTORC1-mediated NRBF2 phosphorylation functions as a switch for the class III PtdIns3K and autophagy. Autophagy, 2017 (In press).
81. Gao, Z.; Yin, J.; Zhang, J.; Ward, R.E.; Martin, R.J.; Lefevre, M.; Cefalu, W.T.; Ye, J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes, 2009, 58, 1509-1517.
82. Yamashita, H.; Fujisawa, K.; Ito, E.; Idei, S.; Kawaguchi, N.; Kimoto, M.; Hiemori, M.; Tsuji, H. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci. Biotechnol. Biochem., 2007, 71, 1236-1243.
83. De Vadder, F.; Kovatcheva-Datchary, P.; Goncalves, D.; Vinera, J.; Zitoun, C.; Duchampt, A.; Backhed, F.; Mithieux, G. Microbiotagenerated metabolites promote metabolic benefits via gut-brain neural circuits. Cell, 2014, 156, 84-96.
84. Chambers, E.S.; Viardot, A.; Psichas, A.; Morrison, D.J.; Murphy, K.G.; Zac-Varghese, S.E.K.; MacDougall, K.; Preston, T.; Tedford, C.; Finlayson, G.S. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut, 2015, 64, 1744-1754.
85. Freeland, K.R.; and Wolever, T.M.S. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br. J. Nutr. 2012, 103, 460-466.
86. Soret, R.; Chevalier, J.; De Coppet, P.; Poupeau, G.; Derkinderen, P.; Segain, J.P.; Neunlist, M. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology, 2010, 138, 1772-1782.
87. Nøhr, M.K.; Egerod, K.L.; Christiansen, S.H.; Gille, A.; Offermanns, S.; Schwartz, T.W.; Møller, M. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience, 2015, 290, 126-137.
88. Kimura, I.; Ozawa, K.; Inoue, D.; Imamura, T.; Kimura, K.; Maeda, T.; Terasawa, K.; Kashihara, D.; Hirano, K.; Tani, T. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun., 2013, 4, 1829.
89. Erny, D.; Hrabe de Angelis, A.L.; Jaitin, D.; Wieghofer, P.; Staszewski, O.; David, E.; Keren-Shaul, H.; Mahlakoiv, T.; Jakobshagen, K.; Buch, T. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci., 2015, 18, 965-977.
90. Braniste, V.; Al-Asmakh, M.; Kowal, C.; Anuar, F.; Abbaspour, A.; Toch, M.; Korecka, A.; Bakocevic, N.; Ng, L.G.; Kundu, P. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med., 2014, 6, 263ra158.
91. Han, M.; Song, P.; Huang, C.; Rezaei, A.; Brown, M.A.; Ma, X. Dietary grape seed proanthocyanidins (GSPs) improve weaned intestinal microbiota and mucosal barrier using a piglet model. Oncotarget. 2016, 7, 80313-80326.